Pooled statistical meta-analyses and systematic reviews aggregating thousands of patients across multiple randomized controlled trials to measure true effect size. Every study summary reports the trial design, participant sample size (N), primary outcome highlight, and direct link to the formal NCBI PubMed or federal record.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
PDE5is could be an effective treatment modality for female sexual dysfunction.
Of 2236 abstracts identified through a systematic literature review, 30 RCTs published between 2003 and 2013 were included.
Although there was a significant reduction in AHI with OPT, the baseline AHI was not suppressed in majority of patients to the extent to call these patients as optimally treated.
Strong evidence exists that standard CT, non-conventional therapy and infradiaphragmatic RT are associated with an increased risk of TD in TGCC-patients when compared with orchiectomy alone.
In patients with hypertriglyceridemia, LDL-C reduction was substantial and dependent on the choice and dose of statin.
The available data suggest that metformin exposure during the first trimester is not associated with major congenital malformations; that metformin reduces the risk of early pregnancy loss, preeclampsia, preterm delivery, and...
Our data suggest that TS is able to improve body composition and glycometabolic profile particularly in younger subjects and in those with metabolic disturbances.
The clinical implication of these results, the possible causal mechanisms of the cognitive impairments and the implication of these for future research were each discussed.
Infertility is not an identified risk factor for breast cancer.
When added to metformin and a sulphonylurea, antihyperglycaemic agents had varying effects on real-world benefits and safety endpoints.
Glossectomy significantly improves sleep outcomes as part of multilevel surgery in adult patients with OSA.
The AASM and AADSM expect these guidelines to have a positive impact on professional behavior, patient outcomes, and, possibly, health care costs.
Of 34 clinical trials, none had adequate safety reporting, 19 were partially adequate, 12 were inadequate, and 3 reported no side effects.
In total, 16 studies of vitiligo and 17 studies of AA were included in the review.
From searches in four databases, 34 articles were included in the quantitative analyses.
Current literature demonstrates that myofunctional therapy decreases apnea-hypopnea index by approximately 50% in adults and 62% in children.
Furthermore, estrogen additive therapy by with diethylstilbestrol or ethinylestradiol has recently been revived and showed a high response rate as a salvage endocrine therapy, although its mechanism of action is still unclear.
AD has been described as an allergic skin disease, but today, the contribution of allergic reactions to the initiation of AD is challenged, and it is proposed that allergy is rather a consequence of AD in subjects with a...
Adding different AHAs to metformin was associated with varying effects on HbA1c, BW, SBP, low blood sugar, UTI and GTI which should impact clinician choice when selecting add-on treatment.
Despite significant clinical efficacy, cosmetically acceptable results are present in only a subset of patients.
This study has limitations, the main being that the search period was restricted to 5 years.
In this communication, the present authors conducted an analysis of completed and ongoing studies of minoxidil response testing.
Based on an informal comparison with atorvastatin, this represents a three-fold greater potency.
The present systematic review and meta-analysis does not support a causal role between TS and adverse CV events.
Results showed combination therapy was safe and could gain better outcomes in blood sugar control.
Amlodipine reduced the risk of total heart and blood vessel events as well as all-cause mortality compared with non-CCB-based regimens, indicating its benefit for high-risk cardiac patients.
Patients with OSA appear to have increased high cholesterol (high total cholesterol, LDL, TG, and low HDL).
Tracheostomies significantly decrease apnea index, oxygen desaturation index, sleepiness, and mortality in OSA subjects.
The BP lowering effect with amlodipine/losartan and amlodipine/valsartan was comparable.
Our results could represent an interesting point of view in the perspective of choosing the most suitable therapy based on clinical and social features for each patient.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
